Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

What Is the New Coronavirus Mutation? More Contagious, but Does It Cause More Severe Covid?

What Is the New Coronavirus Mutation? More Contagious, but Does It Cause More Severe Covid?

Mutation is a change in a DNA or RNA sequence that can have mild or severe consequences. While mutations in DNA are permanent, those in RNA may be temporary because of its fragile structure.

Viruses can acquire mutations that give them different capabilities.

Can a mutation make Covid-19 more contagious?

Science published an article reporting that the novel coronavirus (SARS-CoV-2) had mutated in a way that would make it spread more rapidly worldwide. The new coronavirus variant called D614G emerged in Europe.

NOTE: Variants are mutations that do not change the virus's overall identity. Strains are mutations that give the virus a different identity. In other words, if this happens, everything starts over. Not every nucleotide change means that a virus has become different. Although some call the form named D614G, arising from genetic changes in SARS-CoV-2, both a variant and a strain, we use variant in the rest of this article.

The University of North Carolina at Chapel Hill (UNC) and the University of Wisconsin-Madison showed that the D614G variant replicates faster and is more contagious than the original SARS-CoV-2 that originated in China and started the pandemic.

Although the D614G variant spreads faster, animal studies found that more severe Covid-19 was not associated with it and that the variant was slightly less susceptible to neutralizing antibody drugs.

Another analysis of more than 25,000 viral sequences in the United Kingdom also showed that viruses with these mutations spread faster and caused larger infection clusters.

People with the G614 variant had significantly more viral particles in their nose and throat at diagnosis, probably as a result of increased contagiousness. However, there was no evidence that they ultimately experienced more severe disease.

Study 1 – University of Texas, Austin

Researchers at Houston Methodist Hospital, working with scientists at the University of Texas, Austin, and the University of Chicago, Illinois, also identified 285 other mutations causing changes in the amino acid sequence of the spike protein. They discovered that one mutation allowed the spike to evade a neutralizing antibody produced by the human immune system.

It is unclear whether this mutation also increases contagiousness. However, it was reported to be rare for now and not to cause more severe disease.

The team also found no evidence that the virus had acquired mutations that could render developing vaccines or existing antibody treatments ineffective.

However, Ilya J. Finkelstein, a molecular biologist at the University of Texas and co-author of the study, insists on continued vigilance.

Finkelstein says “The virus continues to mutate as it ravages the world. Real-time surveillance, as in our study, will allow vaccines and therapeutics worldwide to stay one step ahead”.

Study 2 – University of North Carolina, Chapel Hill

At the Chapel Hill Gillings School of Global Public Health, Professor of Epidemiology and at the UNC School of Medicine, Professor of Microbiology and Immunology Ralph Baric has studied coronaviruses for more than thirty years and played a major role in developing the first FDA-approved treatment for Covid-19, remdesivir. Baric says “The D164G virus is approximately 10 times stronger than the ancestral variant and grows rapidly. It replicates extremely efficiently in primary nasal epithelial cells (in the nose), a potentially important region for person-to-person transmission”.

Researchers in the Baric Laboratory, including first author Yixuan J. Hou, conducted a new study in collaboration with University of Wisconsin-Madison virologists Yoshihiro Kawaoka and Peter Halfmann.

Kawaoka said "The original spike protein had a D at this position, and a G replaced it. Several papers had previously explained that this mutation made the protein more functional and more efficient at entering cells".

The previous study relied on a pseudovirus containing the receptor-binding protein rather than a real virus. Using reverse genetics, Baric's team replicated a matched pair of mutant SARS-CoV-2 viruses encoding D or G at position 614 and compared their basic properties using cell lines, primary human respiratory cells, and mouse and hamster cells.

Kawaoka and Halfmann contributed to the distinctive coronavirus study model using hamsters. The University of Wisconsin-Madison team, including Shiho Chiba, who conducted the hamster experiments, studied replication and airborne transmission of both the original virus and the mutated version created by Baric and Hou.

Both faster replication and greater contagiousness

They found that the mutated virus not only replicated 10 times faster but was also much more contagious.

Some hamsters were inoculated with the original virus and others with the mutated virus. The next day, eight uninfected hamsters were placed in cages next to the infected ones. A partition prevented contact but allowed air to pass between the cages.

Testing for the virus in the uninfected hamsters began on the second day. Airborne transmission occurred with both viruses, but the timing differed. Of the eight hamsters breathing the same air as those with the mutated virus, six acquired the mutant virus within two days, and by the fourth day the virus was observed in all hamsters.

Among hamsters breathing the same air as those infected with the original virus, no transmission was observed on the second day. By the fourth day, however, all were infected.

Kawaoka said "We saw that the mutant virus transmitted through the air better than the original virus, which may explain why this virus is dominant in humans".

The researchers also examined the pathology of the two coronavirus variants. After infection, hamsters actually showed the same viral load and symptoms. Those with the mutated variant lost slightly more weight when ill. This suggests that although the mutated virus was much better at infecting hosts, it still did not cause substantially worse disease.

The researchers caution that animal pathology results may not hold true in human studies.

Conclusion

SARS-CoV-2 is an entirely new human pathogen, and its evolution in human populations is difficult to predict. New variants encoding D614G are continually emerging, such as the newly discovered mink SARS-CoV-2 cluster 5 variant in Denmark. To protect public health as fully as possible, we must continue monitoring and understanding the consequences of these mutations for disease severity, transmission, host range and susceptibility to vaccine-induced immunity.

RELATED TOPICS

Sources

1. Common SARS-CoV-2 mutation may make COVID-19 more susceptible to a vaccine. November 12, 2020 – Science Daily: sciencedaily.com

2. A mutation may have made COVID-19 more contagious. Written by James Kingsland on November 6, 2020 – Fact checked by Alexandra Sanfins, Ph.D. Medical New Today: medicalnewstoday.com

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

What Is the New Coronavirus Mutation? More Contagious, but Does It Cause More Severe Covid?

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy